Clinical Trials Logo
  1. Home
  2. Other
  3. NCT03384589

CIRN Pneumococcal Conjugate Vaccine 1 vs. 2 Dose Priming Study

Streptococcus Pneumoniae Infection Clinical Trial

Official title:
A Randomized Controlled Trial to Compare a 1-dose vs. 2-dose Priming Schedule of 13-valent Pneumococcal Conjugate Vaccine in Canadian Infants; a Canadian Immunization Research Network (CIRN) Study

Clinical Trial Summary

This study is assessing if a reduced dosing schedule (1+1) of the 13-valent pneumococcal conjugate vaccine (PCV13) is non-inferior to the currently used schedule used in most of Canada.The vaccine is currently usually given as 3 doses at 2, 4 and 12 months of age. This study aims to find out if it is possible to achieve the same protection using just 2 doses, at 2 and 12 months.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03384589
Study type Interventional
Source University of British Columbia
Contact
Status Completed
Phase Phase 2/Phase 3
Start date August 23, 2018
Completion date March 31, 2023
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05060146 - Prevention of Pneumococcal Infections: Impact Collaborative Medico-pharmaceutical Care Structured to Improve Vaccination Coverage of Patients at Risk. N/A
Not yet recruiting NCT05017519 - Epidemiology and Household Transmission of Streptococcus Pneumoniae and Respiratory Syncytial Virus
Recruiting NCT05759520 - Phase III Clinical Trial of 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) in Infants Phase 3
Completed NCT05361499 - A Controlled Human Pneumococcal Infection Model (PIM) Study N/A
Active, not recruiting NCT03489018 - The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants Phase 4
Completed NCT03696303 - Determination of the Utility of Pfizer's Pneumococcal Urine Antigen Test in Children 5 Years of Age or Younger With Community Acquired Pneumonia in Guatemala
Active, not recruiting NCT03102840 - Understanding Pneumococcal Carriage and Disease 2017-2020
Completed NCT00189020 - Effect of Two Versus Three Pneumococcal Conjugate Vaccinations Phase 3
Completed NCT02037984 - Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004) Phase 1/Phase 2
Recruiting NCT04944719 - Pneumococcal Nasopharyngeal Colonization as Predictor of Community-Acquired Pneumonia (CAP) in Adults With Chronic Diseases.